Swiss National Bank Catalent, Inc. Transaction History

Swiss National Bank

$150 Billion
Q3 2024

A detailed history of Swiss National Bank transactions in Catalent, Inc. stock. As of the latest transaction made, Swiss National Bank holds 535,800 shares of CTLT stock, worth $32.7 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

535,800

Previous 535,800 -0.0%

Holding current value

$32.7 Million

Previous $30.1 Million 7.72%

% of portfolio

0.02%

Previous 0.02%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	SELL	$53.58 - $57.02 $278,616 - $296,504	-5,200 Reduced 0.96%	535,800 $30.1 Million
Q1 2024 May 07, 2024	SELL	$42.56 - $59.82 $893,760 - $1.26 Million	-21,000 Reduced 3.74%	541,000 $30.5 Million
Q4 2023 Feb 06, 2024	SELL	$32.18 - $46.57 $576,022 - $833,603	-17,900 Reduced 3.09%	562,000 $25.3 Million
Q3 2023 Nov 08, 2023	SELL	$44.2 - $50.2 $3 Million - $3.4 Million	-67,800 Reduced 10.47%	579,900 $26.4 Million
Q2 2023 Aug 09, 2023	SELL	$31.86 - $67.26 $984,474 - $2.08 Million	-30,900 Reduced 4.55%	647,700 $28.1 Million
Q1 2023 May 10, 2023	SELL	$45.44 - $74.26 $722,496 - $1.18 Million	-15,900 Reduced 2.29%	678,600 $44.6 Million
Q4 2022 Feb 08, 2023	SELL	$41.39 - $81.0 $1.76 Million - $3.44 Million	-42,480 Reduced 5.76%	694,500 $31.2 Million
Q3 2022 Nov 09, 2022	SELL	$72.36 - $113.1 $101,304 - $158,340	-1,400 Reduced 0.19%	736,980 $53.3 Million
Q2 2022 Aug 09, 2022	SELL	$87.2 - $114.05 $261,600 - $342,150	-3,000 Reduced 0.4%	738,380 $79.2 Million
Q1 2022 May 09, 2022	BUY	$94.19 - $124.49 $8.84 Million - $11.7 Million	93,800 Added 14.48%	741,380 $82.2 Million
Q4 2021 Feb 08, 2022	SELL	$119.57 - $139.07 $3.1 Million - $3.6 Million	-25,900 Reduced 3.85%	647,580 $82.9 Million
Q3 2021 Nov 08, 2021	SELL	$109.17 - $142.35 $2.26 Million - $2.95 Million	-20,700 Reduced 2.98%	673,480 $89.6 Million
Q2 2021 Aug 06, 2021	BUY	$100.34 - $115.69 $6.1 Million - $7.03 Million	60,780 Added 9.6%	694,180 $75.1 Million
Q1 2021 May 07, 2021	BUY	$101.51 - $125.27 $1.38 Million - $1.7 Million	13,600 Added 2.19%	633,400 $66.7 Million
Q4 2020 Feb 05, 2021	BUY	$85.88 - $105.36 $1.43 Million - $1.75 Million	16,600 Added 2.75%	619,800 $64.5 Million
Q3 2020 Nov 09, 2020	SELL	$72.74 - $92.5 $1.05 Million - $1.33 Million	-14,400 Reduced 2.33%	603,200 $51.7 Million
Q2 2020 Aug 05, 2020	BUY	$48.02 - $79.04 $16 Million - $26.4 Million	333,830 Added 117.64%	617,600 $45.3 Million
Q1 2020 May 08, 2020	BUY	$36.95 - $62.95 $158,885 - $270,685	4,300 Added 1.54%	283,770 $14.7 Million
Q4 2019 Feb 06, 2020	BUY	$47.06 - $56.64 $249,418 - $300,192	5,300 Added 1.93%	279,470 $15.7 Million
Q3 2019 Nov 12, 2019	BUY	$47.45 - $58.05 $151,840 - $185,760	3,200 Added 1.18%	274,170 $13.1 Million
Q2 2019 Aug 02, 2019	BUY	$39.26 - $54.21 $235,560 - $325,260	6,000 Added 2.26%	270,970 $14.7 Million
Q1 2019 May 10, 2019	BUY	$29.84 - $43.92 $262,592 - $386,496	8,800 Added 3.44%	264,970 $10.8 Million
Q4 2018 Feb 13, 2019	BUY	$29.95 - $46.34 $700,830 - $1.08 Million	23,400 Added 10.05%	256,170 $7.99 Million
Q3 2018 Nov 08, 2018	BUY	$40.12 - $45.55 $40,120 - $45,550	1,000 Added 0.43%	232,770 $10.6 Million
Q1 2018 May 04, 2018	BUY	$39.4 - $47.39 $283,680 - $341,208	7,200 Added 3.21%	231,770 $9.52 Million
Q4 2017 Feb 07, 2018	BUY	$37.27 - $43.02 $197,531 - $228,006	5,300 Added 2.42%	224,570 $9.23 Million
Q3 2017 Nov 03, 2017	BUY	$33.75 - $41.67 $7.4 Million - $9.14 Million	219,270	219,270 $8.75 Million

Others Institutions Holding CTLT

# of Institutions

513

Shares Held

149M

Call Options Held

575K

Put Options Held

2.03M

View Full List

About Catalent, Inc.

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

More about CTLT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Swiss National Bank with notifications on news.

Account

Swiss National Bank Catalent, Inc. Transaction History